Summary
Updated Aug 31, 2026
Peter S. Kim is Director of Entrada Therapeutics, Inc. (TRDA). 3 SEC Form 4 filings on record going back to 2025, most recently on 12 June 2026. Most recent open-market trade: bought $365K of TRDA on 18 June 2025. Lifetime open-market purchases: $732K.
Recent Transactions
2Every recent SEC Form 4 transaction Peter S. Kim has reported, most recent first.
Other Insiders Active in the Same Stocks
Insiders who reported open-market trades in the last 12 months at the companies Peter S. Kim files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Kush Parmar - $3.65M of TRDA open-market activity in the last 12 months
- 5AM Ventures V, L.P. - $3.00M of TRDA open-market activity in the last 12 months
- BAKER BROS. ADVISORS LP - $1.61M of TRDA open-market activity in the last 12 months
- MPM BioVentures 2014, L.P. - $462K of TRDA open-market activity in the last 12 months
- MPM BIOVENTURES 2018, L.P. - $462K of TRDA open-market activity in the last 12 months
- Kory James Wentworth - $434K of TRDA open-market activity in the last 12 months
More Notable Insiders
Other corporate insiders with significant SEC Form 4 track records on InsiderAlpha:
Frequently Asked Questions
Who is Peter S. Kim?
Peter S. Kim is a corporate insider, tracked as Director of Entrada Therapeutics, Inc. (TRDA). InsiderAlpha holds 3 primary Form 4 filings for them, the earliest from 2025, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Peter S. Kim submitted recently?
1 primary Form 4 filing in the last 90 days, covering 1 company.
Has Peter S. Kim been buying or selling stock?
Recorded transactions: 2 open-market purchases ($732K) and 0 open-market sales across all tracked filings.
Where can I see all of Peter S. Kim's SEC filings?
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Learn More
Follow Peter S. Kim and every insider like them
A free account opens the full scored daily plan and every past day, a watchlist for any ticker, and 3 months of price history on every company page. No card.
Free plan available · Paid plans start with a 7-day free trial
